RNAC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cartesian Therapeutics (RNAC) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RNAC is expected to report earnings to fall 40.00% to -89 cents per share on May 09

Cartesian Therapeutics RNAC Stock Earnings Reports

Q1'24

Est.

$-0.90

Q4'23

Missed

by $1.47

Q3'23

Missed

by $1.28

Q2'23

Beat

by $0.01

Q1'23

Missed

by $4.11

The last earnings report on March 07 showed earnings per share of -150 cents, missing the estimate of -2 cents. With 778.47K shares outstanding, the current market capitalization sits at 483.14M.

View a ticker or compare two or three

Compare

RNAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RNAC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RNAC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

704 Quince Orchard Road

Phone

+1 617 923-1400

Employees

Web

https://www.cartesiantherapeutics.com